Litcius/Paper detail

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer

Yiming Liu, Xinyang Hu, Shiyao Liu, Sining Zhou, Zhi Chen, Hongchuan Jin

2021Frontiers in Oncology28 citationsDOIOpen Access PDF

Abstract

-Golgi cisternae and highly expressed in various types of cancer tissues. Since GP73 is a secretory protein and detectable in serum derived from cancer patients, it has been regarded as a novel serum biomarker for the diagnosis of different cancers, especially hepatocellular carcinoma (HCC). However, the functional roles of GP73 in cancer development are still poorly understood. In recent years, it has been discovered that GP73 acts as a multifunctional protein-facilitating cancer progression, and strikingly, it has been identified as a leading factor promoting epithelial-mesenchymal transition (EMT) of cancer cells and causing cancer metastasis. In this review, we have overviewed the latest findings of the functional roles of GP73 in elevating cancer progression, especially in facilitating EMT and cancer metastasis through modulating expression, transactivation, and trafficking of EMT-related proteins. In addition, unsolved research fields of GP73 have been lightened, which might be helpful to elucidate the regulatory mechanisms of GP73 on EMT and provide potential approaches in therapeutics against cancer metastasis.

Topics & Concepts

Epithelial–mesenchymal transitionGolgi apparatusPhosphoproteinMesenchymal stem cellCancer researchTransition (genetics)CancerCell biologyChemistryBiologyMedicinePhosphorylationInternal medicineBiochemistryGeneEndoplasmic reticulumCellular transport and secretionEndoplasmic Reticulum Stress and DiseaseWnt/β-catenin signaling in development and cancer
Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer | Litcius